The Medicaid and CHIP Payment and Access Commission (MACPAC) met on November 2-3 to discuss topics including: improving the managed care appeals process; Medicaid primary language and limited English proficiency data collection; state and managed care plan strategies for unwinding the continuous coverage requirements; medical care advisory committees and beneficiary engagement; interview findings regarding school-based behavioral health services; comparison of states home and community-based services (HCBS); Medicaid payment policies to support the HCBS workforce; and state Medicaid contracts optimizing Medicare Advantage (MA) dual eligible special needs plans (D-SNPs) (MACPAC, November 2-3).
CMS has finalized a 3.4% reduction to the Medicare physician fee schedule. Other policies finalized in the rule are intended to promote health equity, expand access to dental services, and broaden the group of providers eligible for Medicare reimbursement (Inside Health Policy, November 2; Modern Healthcare, November 2).
Providers who are participating in the 340B drug discount program will receive $9 billion by early 2024 to compensate for payment cuts in previous years. The payments are intended to undo reimbursement cuts from 2018 to 2022 (Modern Healthcare, November 6; Modern Healthcare, November 2).
From November 1 through November 8, CMS approved 18 SPAs and has one 1115 waiver out for public comment.